Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'recombinant factor VIIa' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 104 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Eikenboom, JCJ
      Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    2. Cooper, HA; Jones, CP; Campion, E; Roberts, HR; Hedner, U
      Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures

      HAEMOPHILIA
    3. Godreuil, S; Navarro, R; Quittet, P; Landreau, L; Schved, JF; Biron-Andreani, C
      Acquired haemophilia in the elderly is a severe disease: report of five new cases

      HAEMOPHILIA
    4. Ekert, H; Brewin, T; Boey, W; Davey, P; Tilden, D
      Cost-utility analysis of recombinant factor VIIa (NovoSeven((R))) in six children with long-standing inhibitors to factor VIII or IX

      HAEMOPHILIA
    5. Faradji, A; Bonnomet, F; Lecocq, J; Grunebaum, L; Desprez, D; Kern, O; Barbier, L; Sibilia, J
      Knee joint arthroplasty in a patient with haemophilia A and high inhibitortitre using recombinant factor VIIa (NovoSeven((R))): a new case report and review of the literature

      HAEMOPHILIA
    6. Penner, JA
      Haemophilic patients with inhibitors to factor VIII or IX: variables affecting treatment response

      HAEMOPHILIA
    7. Aledort, LM
      Making a therapeutic choice: human versus recombinant fractions - can we do it?

      HAEMOPHILIA
    8. Hoots, WK
      The future of plasma-derived clotting factor concentrates

      HAEMOPHILIA
    9. Blajchman, MA
      Novel platelet products, substitutes and alternatives

      TRANSFUSION CLINIQUE ET BIOLOGIQUE
    10. Castro, RR; Relinque, NB; Alvarez, AC; Montes, JMG; Gutierrez, JMH
      Use of recombinant factor VII in Hepatology

      REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
    11. Meijer, K; Peters, FTM; van der Meer, J
      Recurrent severe bleeding from gastrointestinal angiodysplasia in a patient with von Willebrand's disease, controlled with recombinant factor VIIa

      BLOOD COAGULATION & FIBRINOLYSIS
    12. Hall, RL; Leahy, MF
      Acquired Factor VIII autoantibody: four cases demonstrating the heterogenous nature of this condition and problems involved in diagnosis and treatment

      EUROPEAN JOURNAL OF HAEMATOLOGY
    13. Robbins, D; Kulkarni, R; Gera, R; Scott-Emuakpor, AB; Bosma, K; Penner, JA
      Successful treatment of high titer inhibitors in mild hemophilia a with avoidance of factor VIII and immunosuppressive therapy

      AMERICAN JOURNAL OF HEMATOLOGY
    14. Kulkarni, R; Aledort, LM; Berntorp, E; Brackman, HH; Brown, D; Cohen, AR; Ewing, NP; Gringeri, A; Gruppo, R; Hoots, K; Leissenger, C; Peerlinck, K; Poon, MC; Wong, WY
      Therapeutic choices for patients with hemophilia and high-titer inhibitors

      AMERICAN JOURNAL OF HEMATOLOGY
    15. Friederich, PW; Wever, PC; Briet, E; Doorenbos, CJ; Levi, M
      Successful treatment with recombinant factor VIIa of therapy-resistant severe bleeding in a patient with acquired von Willebrand disease

      AMERICAN JOURNAL OF HEMATOLOGY
    16. Smith, MP; Ludlam, CA; Collins, PW; Hay, CRM; Wilde, JT; Grigeri, A; Melsen, T; Savidge, GF
      Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII - Plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleeding

      THROMBOSIS AND HAEMOSTASIS
    17. Blatt, J; Gold, SH; Wiley, JM; Monahan, PE; Cooper, HC; Harvey, D
      Off-label use of recombinant factor VIIa in patients following bone marrowtransplantation

      BONE MARROW TRANSPLANTATION
    18. Levesque, H; Borg, JY; Bossi, P; Goudemand, J; Guillet, B; Cabane, J
      Acquired haemophilia: diagnosis and therapeutic management.

      REVUE DE MEDECINE INTERNE
    19. Erhardtsen, E; Nilsson, P; Johannessen, M; Thomsen, MS
      Pharmacokinetics and safety of FFR-rFVIIa after single doses in healthy subjects

      JOURNAL OF CLINICAL PHARMACOLOGY
    20. Tomokiyo, K; Teshima, K; Nakatomi, Y; Watanabe, T; Mizuguchi, J; Nozaki, C; Nakagaki, T; Miyamoto, S; Funatsu, A; Iwanaga, S
      Induction of acquired factor IX inhibitors in cynomolgus monkey (Macaca fascicularis): A new primate model of hemophilia B

      THROMBOSIS RESEARCH
    21. Elg, M; Carlsson, S; Gustafsson, D
      Effects of agents, used to treat bleeding disorders, on bleeding time prolonged by a very high dose of a direct thrombin inhibitor in anesthesized rats and rabbits

      THROMBOSIS RESEARCH
    22. Shapiro, A
      Inhibitor treatment: State of the art

      SEMINARS IN HEMATOLOGY
    23. Lee, DH; Blajchman, MA
      Novel treatment modalities: New platelet preparations and subsititutes

      BRITISH JOURNAL OF HAEMATOLOGY
    24. Kulkarni, R; Lusher, J
      Perinatal management of newborns with haemophilia

      BRITISH JOURNAL OF HAEMATOLOGY
    25. Smyth, SS; Reis, ED; Vaananen, H; Zhang, W; Coller, BS
      Variable protection of beta 3-integrin-deficient mice from thrombosis initiated by different mechanisms

      BLOOD
    26. Bayani, N; Lelong, F
      Acquired factor VIIIc inhibitors. Two cases and a review of the literature

      ANNALES DE MEDECINE INTERNE
    27. Martinowitz, U; Holcomb, JB; Pusateri, AE; Stein, M; Onaca, N; Freidman, M; Macaitis, JM; Castel, D; Hedner, U; Hess, JR
      Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries

      JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE
    28. Lusher, JM
      Inhibitors in young boys with haemophilia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    29. Unuvar, A; Warrier, I; Lusher, JM
      Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors

      HAEMOPHILIA
    30. Cohen, I; Heim, M; Martinowitz, U; Chechick, A
      Orthopaedic outcome of total knee replacement in Haemophilia A

      HAEMOPHILIA
    31. Ton-That, TT; Doron, D; Pollard, BS; Bacher, J; Pollard, HB
      In vivo bypass of hemophilia A coagulation defect by Factor XIIa implant

      NATURE BIOTECHNOLOGY
    32. Shord, SS; Lindley, CM
      Coagulation products and their uses

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    33. Johannessen, M; Andreasen, RB; Nordfang, O
      Decline of factor VIII and factor IX inhibitors during long-term treatmentwith NovoSeven (R)

      BLOOD COAGULATION & FIBRINOLYSIS
    34. Negrier, C; Lienhart, A
      Overall experience with NovoSeven (R)

      BLOOD COAGULATION & FIBRINOLYSIS
    35. Ingerslev, J; Christiansen, K; Calatzis, A; Holm, M; Ebbesen, LS
      Management and monitoring of recombinant activated factor VII

      BLOOD COAGULATION & FIBRINOLYSIS
    36. McPherson, J; Sutcharitchan, P; Lloyd, J; Street, A; Jorgensen, LN; Yang, SI
      Experience with continuous infusion of recombinant activated factor VII inthe Asia-Pacific region

      BLOOD COAGULATION & FIBRINOLYSIS
    37. Lusher, JM
      Acute hemarthroses: the benefits of early versus late treatment with recombinant activated factor VII

      BLOOD COAGULATION & FIBRINOLYSIS
    38. Poon, MC; d'Oiron, R
      Recombinant activated factor VII (NovoSeven (R)) treatment of platelet-related bleeding disorders

      BLOOD COAGULATION & FIBRINOLYSIS
    39. Rapaport, SI
      Coagulation problems in liver disease

      BLOOD COAGULATION & FIBRINOLYSIS
    40. Manzano, ML; Arocena, C; Tomas, JF; Hedner, U; Quiroga, JA; Carreno, V
      Measurement of the procoagulant activity of factor VII in patients with liver cirrhosis and normal prothrombin activity: evaluation of the bleeding risk

      BLOOD COAGULATION & FIBRINOLYSIS
    41. Hedner, U
      NovoSeven (R) as a universal haemostatic agent

      BLOOD COAGULATION & FIBRINOLYSIS
    42. Friederich, PW; Geerdink, MGF; Spataro, M; Messelink, EJ; Henny, CP; Buller, HR; Levi, M
      The effect of the administration of recombinant activated factor VII (NovoSeven (R)) on perioperative blood loss in patients undergoing transabdominal retropubic prostatectomy: the PROSE study

      BLOOD COAGULATION & FIBRINOLYSIS
    43. Golino, P; Ragni, M; Cirillo, P; D'Andrea, D; Ravera, M; Calabro, P; Ezban, M; Tommasini, P; Chiariello, M
      Effects of recombinant active site-blocked activated factor VII in rabbit models of carotid stenosis and myocardial infarction

      BLOOD COAGULATION & FIBRINOLYSIS
    44. Johannessen, M; Nielsen, G; Nordfang, O
      Comparison of the factor VII : C clot analysis and a modified activated factor VII analysis for monitoring factor VII activity in patients treated with recombinant activated factor VII (NovoSeven (R))

      BLOOD COAGULATION & FIBRINOLYSIS
    45. Liebman, HA; Chediak, J; Fink, KI; Galvez, AG; Shah, PC; Sham, RL
      Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIII

      AMERICAN JOURNAL OF HEMATOLOGY
    46. d'Oiron, R; Menart, C; Trzeciak, MC; Nurden, P; Fressinaud, E; Dreyfus, M; Laurian, Y; Negrier, C
      Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thrombasthenia undergoing inversive procedures

      THROMBOSIS AND HAEMOSTASIS
    47. Hedner, U
      Recombinant coagulation factor VIIa: From the concept to clinical application in hemophilia treatment in 2000

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    48. Schulman, S
      Continuous infusion of recombinant factor VIIa in hemophilic patients withinhibitors: Safety, monitoring, and cost effectiveness

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    49. Ingerslev, J
      Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    50. Lusher, JM
      Inhibitor antibodies to factor VIII and factor IX: Management

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    51. Engelfriet, CP; Reesink, HW; Mannucci, PM; Gringeri, A; Ingerslev, J; Brettler, DB; Mauser-Bunschoten, EP; Negrier, C; Berntorp, E; Smith, OP; Shapiro, AD
      The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies

      VOX SANGUINIS
    52. Hough, RE; Hampton, KK; Preston, FE; Channer, KS; West, J; Makris, M
      Recombinant VIIa concentrate in the management of bleeding following prothrombin complex concentrate-related myocardial infarction in patients with haemophilia and inhibitors

      BRITISH JOURNAL OF HAEMATOLOGY
    53. Hay, CRM; Baglin, TP; Collins, PW; Hill, FGH; Keeling, DM
      The diagnosis and management of factor VIII and IX inhibitors: A guidelinefrom the UK Haemophilia Centre Doctors' Organization (UKHCDO)

      BRITISH JOURNAL OF HAEMATOLOGY
    54. van't Veer, C; Golden, NJ; Mann, KG
      Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa

      BLOOD
    55. Scharrer, I; Grossmann, R
      Acquired inhibitory body hemophilia

      ANAESTHESIST
    56. Barthels, M
      Current diagnosis and treatment - The effect of inhibitors on the use of clotting factor concentrates

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    57. Kanyike, FB; Abdul-Salam, SA; Prakash, B; Sharhan, A; Wahib, N; Youssef, AH
      Use of recombinant factor VIIa (NovoSeven) in a haemophilia A patient withinhibitor in Kuwait

      HAEMOPHILIA
    58. Leach, M; Makris, M; Hampton, KK; Preston, FE
      Spinal epidural haematoma in haemophilia A with inhibitors - efficacy of recombinant factor VIIa concentrate

      HAEMOPHILIA
    59. McColl, MD; Omran, A; Walker, ID; Lowe, GDO
      Acute renal failure complicating high-dose intravenous immunoglobulin therapy for acquired haemophilia

      HAEMOPHILIA
    60. Lorenzo, JI; Montoro, JM; Aznar, JA
      Postoperative use of rFVIIa by continuous infusion in a haemophilic boy

      HAEMOPHILIA
    61. Freiburghaus, C; Berntorp, E; Ekman, M; Gunnarsson, M; Kjellberg, BM; Nilsson, IM
      Tolerance induction using the Malmo treatment model 1982-1995

      HAEMOPHILIA
    62. Green, D
      Complications associated with the treatment of haemophiliacs with inhibitors

      HAEMOPHILIA
    63. Teitel, JM
      Recombinant factor VIIa versus aPCCs in haemophiliacs with inhibitors: treatment and cost considerations

      HAEMOPHILIA
    64. Scaraggi, FA; De Mitrio, V; Marino, R; Speciale, V; Di Bari, L; Petronelli, M; Schiraldi, O
      Treatment with recombinant activated factor VII in a patient with hemophilia A and an inhibitor: advantages of administration by continuous infusion over bolus intermittent injections

      BLOOD COAGULATION & FIBRINOLYSIS
    65. Barthels, M
      Clinical efficacy of prothrombin complex concentrates and recombinant factor VIIa in the treatment of bleeding episodes in patients with factor VIII and IX inhibitors

      THROMBOSIS RESEARCH
    66. Ingerslev, J; Sneppen, O; Hvid, I; Fredberg, U; Kristensen, HL; Sindet-Petersen, S
      Treatment of acute bleeding episodes with rFVIIa

      VOX SANGUINIS
    67. SCHULMAN S
      SAFETY, EFFICACY AND LESSONS FROM CONTINUOUS-INFUSION WITH RFVIIA

      Haemophilia
    68. INGERSLEV J; KRISTENSEN HL
      CLINICAL PICTURE AND TREATMENT STRATEGIES IN FACTOR-VII DEFICIENCY

      Haemophilia
    69. Lusher, JM; Roberts, HR; Davignon, G; Joist, JH; Smith, H; Shapiro, A; Laurian, Y; Kasper, CK; Mannucci, PM
      A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors

      HAEMOPHILIA
    70. MENART C; COGNET V; PETIT PY; MASSIGNON D; NEGRIER C
      MANAGEMENT OF AN ANTI-FACTOR-VIII INHIBITOR OCCURRING DURING SURGICAL-PROCEDURE WITH CONTINUOUS-INFUSION OF NOVOSEVEN(R)

      Blood coagulation & fibrinolysis
    71. LUSHER J; INGERSLEV J; ROBERTS H; HEDNER U
      CLINICAL-EXPERIENCE WITH RECOMBINANT FACTOR VIIA

      Blood coagulation & fibrinolysis
    72. MONROE DM; HOFFMAN M; OLIVER JA; ROBERTS HR
      A POSSIBLE MECHANISM OF ACTION OF ACTIVATED FACTOR-VII INDEPENDENT OFTISSUE FACTOR

      Blood coagulation & fibrinolysis
    73. HOFFMAN M; MONROE DM; ROBERTS HR
      ACTIVATED FACTOR-VII ACTIVATES FACTOR-IX AND FACTOR-X ON THE SURFACE OF ACTIVATED PLATELETS - THOUGHTS ON THE MECHANISM OF ACTION OF HIGH-DOSE ACTIVATED FACTOR-VII

      Blood coagulation & fibrinolysis
    74. INGERSLEV J; THYKJAER H; JENSEN OK; FREDBERG U
      HOME TREATMENT WITH RECOMBINANT ACTIVATED FACTOR-VII - RESULTS FROM ONE-CENTER

      Blood coagulation & fibrinolysis
    75. INGERSLEV J; HOLM M; CHRISTIANSEN K; KNUDSEN L; NEGRIER C
      LEVELS OF PROTHROMBIN ACTIVATION PEPTIDE F1+2 IN PATIENTS WITH A BLEEDING TENDENCY

      Blood coagulation & fibrinolysis
    76. MARCKMANN P; BLADBJERG EM; JESPERSEN J
      DIET AND BLOOD-COAGULATION FACTOR-VII - A KEY PROTEIN IN ARTERIAL THROMBOSIS

      European journal of clinical nutrition
    77. Hay, CRM
      Acquired haemophilia

      BAILLIERES CLINICAL HAEMATOLOGY
    78. Vermylen, J; Peerlinck, K
      Optimal care of inhibitor patients during surgery

      EUROPEAN JOURNAL OF HAEMATOLOGY
    79. SHAPIRO AD; GILCHRIST GS; HOOTS WK; COOPER HA; GASTINEAU DA
      PROSPECTIVE, RANDOMIZED TRIAL OF 2 DOSES OF RFVIIA (NOVOSEVEN) IN HEMOPHILIA PATIENTS WITH INHIBITORS UNDERGOING SURGERY

      Thrombosis and haemostasis
    80. Mauser-Bunschoten, EP; de Goede-Bolder, A; Wielenga, JJ; Levi, M; Peerlinck, K
      Continuous infusion of recombinant factor VIIa in patients with haemophilia and inhibitors - Experience in the Netherlands and Belgium.

      NETHERLANDS JOURNAL OF MEDICINE
    81. TAKAHASHI I; YAKO F; SAITO H; KAMIYA T
      CHANGE OF ANTIGENIC AND NEUTRALIZING SPECIFICITY IN SUBSTITUTIONAL EPITOPE PEPTIDES OF HEMOPHILIA-B INHIBITOR

      Peptides (New York, N.Y. 1980)
    82. SHAH AM; KISIEL W; FOSTER DC; NELSESTUEN GL
      MANIPULATION OF THE MEMBRANE-BINDING SITE OF VITAMIN-K-DEPENDENT PROTEINS - ENHANCED BIOLOGICAL FUNCTION OF HUMAN FACTOR-VII

      Proceedings of the National Academy of Sciences of the United Statesof America
    83. BOSSI P; CABANE J; NINET J; DHOTE R; HANSLIK T; CHOSIDOW O; JOUANFLAHAULT C; HORELLOU MH; LEYNADIER F; LIOZON E; POUCHOT J; ROBIN JP; SANDERSON F; SCHAEFFER A; SICARD D; STAIKOWSKY F; WECHSLER B; ZITTOUN R
      ACQUIRED HEMOPHILIA DUE TO FACTOR-VIII INHIBITORS IN 34 PATIENTS

      The American journal of medicine
    84. WARRIER I; EWENSTEIN BM; KOERPER MA; SHAPIRO A; KEY N; DIMICHELE D; MILLER RT; PASI J; RIVARD GE; SOMMER SS; KATZ J; BERGMANN F; LJUNG R; PETRINI P; LUSHER JM
      FACTOR-IX INHIBITORS AND ANAPHYLAXIS IN HEMOPHILIA-B

      Journal of pediatric hematology/oncology
    85. COBOS E; KEUNG YKK; AKHTER S; JONES J
      USE OF RECOMBINANT FACTOR VIIA FOR MAJOR ELECTIVE SURGERY IN A PATIENT WITH FACTOR-VII DEFICIENCY, RETROPERITONEAL FIBROSIS AND HYDRONEPHROSIS

      Clinical and applied thrombosis/hemostasis
    86. MONROE DM; HOFFMAN M; OLIVER JA; ROBERTS HR
      PLATELET ACTIVITY OF HIGH-DOSE FACTOR VIIA IS INDEPENDENT OF TISSUE FACTOR

      British Journal of Haematology
    87. SHAFI T; JEHA MT; BLACK L; ALDOURI M
      SEVERE ACQUIRED HEMOPHILIA-A TREATED WITH RECOMBINANT FACTOR VIIA

      British Journal of Haematology
    88. BRETTLER DB
      INHIBITORS IN CONGENITAL HEMOPHILIA

      Bailliere's clinical haematology
    89. NICOLAISEN EM
      LONG-TERM FOLLOW-UP WITH REGARD TO POTENTIAL IMMUNOGENICITY - CLINICAL-EXPERIENCE WITH NOVOSEVEN(R) (RECOMBINANT FACTOR VIIA)

      Haemostasis
    90. HEDNER U
      DOSING AND MONITORING NOVOSEVEN(R) TREATMENT

      Haemostasis
    91. MCPHERSON J; TEAGUE L; LLOYD J; JUPE D; ROWELL J; OCKELFORD P; EKERT H; STREET A; FAASE A; HEDNER U
      EXPERIENCE WITH RECOMBINANT FACTOR VIIA IN AUSTRALIA AND NEW-ZEALAND

      Haemostasis
    92. INGERSLEV J; FREIDMAN D; GASTINEAU D; GILCHRIST G; JOHNSSON H; LUCAS G; MCPHERSON J; PRESTON E; SCHEIBEL E; SHUMAN M
      MAJOR SURGERY IN HEMOPHILIC PATIENTS WITH INHIBITORS USING RECOMBINANT FACTOR VIIA

      Haemostasis
    93. RICE KM; SAVIDGE GF
      NOVOSEVEN(R) (RECOMBINANT FACTOR VIIA) IN CENTRAL-NERVOUS-SYSTEM BLEEDS

      Haemostasis
    94. BECH RM
      RECOMBINANT FACTOR VIIA IN JOINT AND MUSCLE BLEEDING EPISODES

      Haemostasis
    95. YOSHIOKA A; NISHIO K; SHIMA M
      THROMBELASTGRAM AS A HEMOSTATIC MONITOR DURING RECOMBINANT FACTOR VIIA TREATMENT IN HEMOPHILIA-A PATIENTS WITH INHIBITOR TO FACTOR-VIII

      Haemostasis
    96. SHAPIRO AD
      AMERICAN EXPERIENCE WITH HOME-USE OF NOVOSEVEN(R) - RECOMBINANT FACTOR VIIA IN HEMOPHILIACS WITH INHIBITORS

      Haemostasis
    97. CIAVARELLA N; SCHIAVONI M; VALENZANO E; MANGINI F; INCHINGOLO F
      USE OF RECOMBINANT FACTOR-VIIA (NOVOSEVEN(R)) IN THE TREATMENT OF 2 PATIENTS WITH TYPE-III VONWILLEBRANDS-DISEASE AND AN INHIBITOR AGAINST VONWILLEBRAND-FACTOR

      Haemostasis
    98. KRISTENSEN J; KILLANDER A; HIPPE E; HELLEBERG C; ELLEGARD J; HOLM M; KUTTI J; MELLQVIST UH; JOHANSSON JE; GLAZER S; HEDNER U
      CLINICAL-EXPERIENCE WITH RECOMBINANT FACTOR VIIA IN PATIENTS WITH THROMBOCYTOPENIA

      Haemostasis
    99. SMITH OP; HANN IM
      RVIIA THERAPY TO SECURE HEMOSTASIS DURING CENTRAL LINE INSERTION IN CHILDREN WITH HIGH-RESPONDING FVIII INHIBITORS

      British Journal of Haematology
    100. BRETTLER DB
      INHIBITORS OF FACTOR-VIII AND FACTOR-IX

      Haemophilia


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 15:54:14